Global ribonucleic acid (RNA) markers market is estimated to be valued at US$ 226.6 million in 2023 and is expected to exhibit a CAGR of 8.76% during the forecast period (2023-2030). Increasing investment for research and development activities by the government is expected to assist in the growth of the market over the forecast period. For instance, in the year 2020, Sanofi, a pharmaceutical company and GSK, a pharmaceutical and Biotechnology Company, entered into a collaboration agreement with the U.S. government, in order to increase the development and manufacturing of a COVID-19 recombinant protein-based vaccine. Under this agreement, the U.S. government provided US$ 2.1 billion, which was used for the development of vaccine, clinical trials, scale up and distribution of approximately 100 million doses of vaccines.
Ribonucleic Acid (RNA) Markers Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients